dr. An Van Den Bulcke (PhD)
As Senior Business Developer, dr. An Van Den Bulcke is responsible for the coordination and facilitation of commercialisation of new research findings to market-ready technologies and products, specifically for biomedical markets (pharma, biotech, diagnostics), personal care (cosmetics) and biomaterials markets. She is the focal point for industrial collaborations and builds a relevant network of life science companies interested in chemical expertise or novel (patented) technologies to boost their innovations. In this way, she is involved i.a.:
- Managing the portfolio of collaborations with academic and industrial partners
- Building and managing a strategic IP portfolio
- Prospecting licensing opportunities and negotiating licensing deals
- Creation of spin-off companies
Specialties: research & innovation management - technology transfer - project portfolio management - out-licensing - intellectual property - technology & business development
Chemtech area's of expertise: Novel Bioconjugate Chemistries, Natural Compounds & analogues, Nanocarriers, Controlled Drug Delivery and Nanomedicines, Smart Polymeric Materials, Polymer therapeutics, Biomaterials, Electrospinning & 3D printing, materials for regenerative medicine Advanced Characterisation Analysis.
An Van Den Bulcke holds a Ph.D in Chemistry (Polymer Synthesis) and has an industrial career in product development and R&D management. In 2011 she started as Business Developer at ChemTech, the Chemistry Business and Valorisation cluster at Ghent University. ChemTech is a consortium of 20 research groups active in (Bio)Organic Synthesis, Polymer Chemistry, Anorganic research and Advanced Analytical Chemistry.
An is co-founder and member of the management board of the CBI-cluster, "Chemistry to foster Biology Innovation" an inter-university initiative linking chemical expertise in Flanders (UA, KULeuven, UGent, UHasselt and VUB) with the biology community.